India: Actis Capital eyes $280m Symbiotec Pharmalab exit

India: Actis Capital eyes $280m Symbiotec Pharmalab exit

Reghu Balakrishnan

11 September, 2016

Actis CapitalGland Pharma LtdKKR & CoParas Pharmaceuticals LtdPricewaterhouseCoopers IndiaReckitt Benckiser Group Plc.Symbiotec Pharmalab Ltd

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

Read more from India

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.